The document is a Quarterly Activities/Appendix 4C Cash Flow Report for Alexium International Group Limited for the quarter ending on 31 December 2025. The report details the company's financial activities, including cash flows from operations, investing, and financing activities. Alexium International Group has made significant progress with its acquisition of Microtek Laboratories, which strengthens its product and manufacturing capabilities, particularly in the microencapsulated phase change materials (mPCM) and flame-resistant textiles sectors. Despite a decline in sales due to market conditions, the company maintains strong support from shareholders and lenders, and is poised for growth with new business opportunities. The report also highlights the company's cash flow situation, with $398,000 in cash and cash equivalents at the end of the quarter, and ongoing efforts to manage expenses and optimize cash conversion cycles. Key financial activities include proceeds from borrowings and a successful entitlement offer raising $4.6 million to support the next phase of growth.
Key Points
Quarterly Activities/Appendix 4C Cash Flow Report for the period ending 31 December 2025.
Acquisition of Microtek Laboratories to enhance mPCM and flame-resistant technologies.
Sales decreased due to weak consumer sentiment in the US mattress market.
Strong support from shareholders and lenders, with positive cash flow expectations from new opportunities.
Successful entitlement offer raised $4.6 million for debt reduction and working capital.
Cash and cash equivalents at end of quarter were $398,000.
Proceeds from borrowings and financing activities are prioritized.
Focus on expense management and optimization of cash conversion cycle.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.